News

India bioenergy gains momentum post E20 mandate Optimism builds for the future

The Next Frontier in Aviation: Sustainable Aviation Fuel (SAF).

Mar 02, 2026

By : Team ABLE

Cipla and Kemwell form biologics JV to tap fast growing biosimilars market

A new company will be incorporated in which Cipla will hold a 60 per cent stake while Kemwell will own the remaining 40 per cent.

Mar 02, 2026

By : Team ABLE

Lupin CEO Vinita Gupta honoured in CNBC 2026 Changemakers List

Lupin Limited is a leading Mumbai-based multinational pharmaceutical company, founded in 1968, specializing in generic and branded formulations, complex generics, and APIs. With a global presence, it focuses on therapeutic areas like cardiovascular, respiratory, and anti-diabetics, ranking high in sustainability and supplying essential medicines to over 100 markets.

Feb 28, 2026

By : Team ABLE

Rajasthan Biotech Conclave 2026

Rajasthan Biotech Conclave 2026 is the flagship program jointly organized by Dr. B. Lal Institute of Biotechnology and AIC–Banasthali Vidyapith.

Feb 26, 2026

By : Team ABLE

Lupin launches Brivaracetam Oral Solution in US

Brivaracetam oral solution is an antiepileptic medication used to treat partial-onset seizures in patients 2 years and older, often as an add-on therapy.

Feb 24, 2026

By : Team ABLE